Antisense Therapeutics Limited (AU:PER) has released an update.
Percheron Therapeutics Limited has announced plans to issue 27.5 million ordinary fully paid securities, with the proposed issuance date set for November 27, 2024. This move is part of a strategic placement aimed at raising capital and potentially boosting the company’s market presence. Investors should keep an eye on how this development impacts Percheron’s stock performance and market valuation.
For further insights into AU:PER stock, check out TipRanks’ Stock Analysis page.
